Your browser doesn't support javascript.
loading
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients.
Cuker, Adam; Tseng, Eric K; Schünemann, Holger J; Angchaisuksiri, Pantep; Blair, Clifton; Dane, Kathryn; DeSancho, Maria T; Diuguid, David; Griffin, Daniel O; Kahn, Susan R; Klok, Frederikus A; Lee, Alfred Ian; Neumann, Ignacio; Pai, Ashok; Righini, Marc; Sanfilippo, Kristen M; Siegal, Deborah M; Skara, Mike; Terrell, Deirdra R; Touri, Kamshad; Akl, Elie A; Al Jabiri, Reyad; Al Jabiri, Yazan; Boulos, Mary; Brignardello-Petersen, Romina; Charide, Rana; Colunga-Lozano, Luis E; Dearness, Karin; Darzi, Andrea J; Karam, Samer G; Morgano, Gian Paolo; Morsi, Rami Z; Philip, Binu A; Benitez, Yetiani Roldan; Stevens, Adrienne; Solo, Karla; Wiercioch, Wojtek; Mustafa, Reem A; Nieuwlaat, Robby.
Afiliação
  • Cuker A; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Tseng EK; Division of Hematology/Oncology; St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Schünemann HJ; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Angchaisuksiri P; Institut für Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Blair C; Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Dane K; Union, NJ.
  • DeSancho MT; Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD.
  • Diuguid D; Division of Hematology-Oncology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY.
  • Griffin DO; Division of Hematology, and.
  • Kahn SR; Division of Infectious Diseases, College of Physicians & Surgeons of Columbia University, New York, NY.
  • Klok FA; Research and Development at United Health Group, Minnetonka, MN.
  • Lee AI; Prohealth NY, Lake Success, NY.
  • Neumann I; Department of Medicine, McGill University, Montreal, QC, Canada.
  • Pai A; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
  • Righini M; Section of Hematology, Yale School of Medicine, New Haven, CT.
  • Sanfilippo KM; Escuela de Medicina, Facultad de Medicina y Ciencia, Universidad San Sebastian, Santiago, Chile.
  • Siegal DM; Division of Hematology & Oncology, Kaiser Permanente, Oakland/Richmond, CA.
  • Skara M; Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Terrell DR; Washington University School of Medicine St. Louis, St. Louis, MO.
  • Touri K; Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
  • Akl EA; Cottage Grove, MN.
  • Al Jabiri R; Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Al Jabiri Y; Toronto, ON, Canada.
  • Boulos M; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Brignardello-Petersen R; University of Jordan, Amman, Jordan.
  • Charide R; Lincoln Medical Center, Bronx, NY.
  • Colunga-Lozano LE; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Dearness K; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Darzi AJ; Clinical Research Institute, American University of Beirut, Beirut, Lebanon.
  • Karam SG; Department of Clinical Medicine, Health Science Center, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
  • Morgano GP; Library Services, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.
  • Morsi RZ; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Philip BA; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Benitez YR; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Stevens A; Department of Neurology, University of Chicago, Chicago, IL; and.
  • Solo K; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Wiercioch W; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Mustafa RA; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
  • Nieuwlaat R; Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada.
Blood Adv ; 6(17): 4975-4982, 2022 09 13.
Article em En | MEDLINE | ID: mdl-35748885

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / COVID-19 / Hematologia Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / COVID-19 / Hematologia Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article